Menu
GeneBe

18-47841913-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2

The NM_005901.6(SMAD2):c.1318C>T(p.Leu440Phe) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

SMAD2
NM_005901.6 missense

Scores

8
9
1

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.74
Variant links:
Genes affected
SMAD2 (HGNC:6768): (SMAD family member 2) The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signal of the transforming growth factor (TGF)-beta, and thus regulates multiple cellular processes, such as cell proliferation, apoptosis, and differentiation. This protein is recruited to the TGF-beta receptors through its interaction with the SMAD anchor for receptor activation (SARA) protein. In response to TGF-beta signal, this protein is phosphorylated by the TGF-beta receptors. The phosphorylation induces the dissociation of this protein with SARA and the association with the family member SMAD4. The association with SMAD4 is important for the translocation of this protein into the nucleus, where it binds to target promoters and forms a transcription repressor complex with other cofactors. This protein can also be phosphorylated by activin type 1 receptor kinase, and mediates the signal from the activin. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, May 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_005901.6
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, SMAD2

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SMAD2NM_005901.6 linkuse as main transcriptc.1318C>T p.Leu440Phe missense_variant 11/11 ENST00000262160.11
SMAD2NM_001003652.4 linkuse as main transcriptc.1318C>T p.Leu440Phe missense_variant 11/11
SMAD2NM_001135937.3 linkuse as main transcriptc.1228C>T p.Leu410Phe missense_variant 10/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SMAD2ENST00000262160.11 linkuse as main transcriptc.1318C>T p.Leu440Phe missense_variant 11/111 NM_005901.6 Q15796-1
SMAD2ENST00000402690.6 linkuse as main transcriptc.1318C>T p.Leu440Phe missense_variant 11/111 Q15796-1
SMAD2ENST00000356825.8 linkuse as main transcriptc.1228C>T p.Leu410Phe missense_variant 10/101 P1Q15796-2
SMAD2ENST00000586040.5 linkuse as main transcriptc.1228C>T p.Leu410Phe missense_variant 9/95 P1Q15796-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeApr 07, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMAD2 protein function. This variant has not been reported in the literature in individuals affected with SMAD2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 440 of the SMAD2 protein (p.Leu440Phe). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.43
D
BayesDel_noAF
Pathogenic
0.38
Cadd
Uncertain
25
Dann
Uncertain
1.0
DEOGEN2
Pathogenic
0.98
D;D;.;.
Eigen
Uncertain
0.50
Eigen_PC
Uncertain
0.58
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Uncertain
0.25
D
MetaRNN
Uncertain
0.72
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.2
M;M;.;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-3.0
D;D;D;.
REVEL
Pathogenic
0.78
Sift
Uncertain
0.0030
D;D;D;.
Sift4G
Uncertain
0.0030
D;D;D;D
Polyphen
0.19
B;B;D;D
Vest4
0.65
MutPred
0.68
Loss of stability (P = 0.1126);Loss of stability (P = 0.1126);.;.;
MVP
0.96
MPC
1.5
ClinPred
0.87
D
GERP RS
5.7
Varity_R
0.82
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr18-45368284; API